BONE GROWTH STIMULATOR MARKET ANALYSIS

Bone Growth Stimulator Market Size and Trends

The Global Bone Growth Stimulator Market is estimated to be valued at USD 1.20 Bn in 2024 and is expected to reach USD 1.71 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

Key Takeaways of the Bone Growth Stimulator Market:

• By material type, the bone growth stimulation devices segment is expected to contribute the highest share of the market with 43.1%
• In terms of application, the spinal fusion surgeries segment is expected to contribute the highest share of the market with 34.1% in 2024
• In terms of end user, the hospitals segment is expected to contribute the highest share of the market with 32.2% in 2024
• North America is expected to top the global market with 37.3% share, followed by Asia Pacific with 28.2% share in 2024

Market Overview:

The increasing prevalence of fractures associated with osteoporosis and sports injuries especially in the geriatric and adult population is expected to drive the demand for bone growth stimulators globally. This is attributed to rising cases of spinal fusion surgeries, growing geriatric population who are more prone to osteoporosis, and increasing incidence of sports injuries. Technological advancements in bone growth stimulator devices along with rising awareness regarding the benefits of these devices among patients and healthcare professionals are the key factors expected to support the market growth during the forecast period.

To learn more about this report, Request sample copy

Key Developments:

• In June 2024, Johnson & Johnson MedTech, a division of Johnson & Johnson, a global healthcare company announced that DePuy Synthes received U.S. FDA clearance for the VELYS Robotic-Assisted Solution for Unicompartmental Knee Arthroplasty (UKA) procedures, including medial and lateral applications. This innovation is designed to assist surgeons with precise implant placement without the need for a CT scan.
• In April 2024, Xstim, a pioneering developer and manufacturer of cutting-edge bone growth stimulation systems, announced that its non-invasive, wearable spine fusion stimulator received premarket approval from the U.S. FDA. This device promotes bone healing after spinal fusion surgery by emitting low-energy signals.
• In February 2024, Orthofix Medical Inc., a medical device company appointed Mr. Jason Shallenberger as President of Bone Growth Therapies, following consistent double-digit growth under his leadership in 2023. The company also realigned its Spine and Bone Growth Therapies units to operate under separate Presidents, aligning with its business structure.
• In August 2022, Theragen, a medical device company, announced receiving a U.S. patent for its ActaStim-S Spine Fusion Bone Growth Stimulator system. This innovative device combines proven therapeutic stimulation with a modern design and a digital health platform, enhancing healing, patient compliance, and communication with healthcare providers during the post-operative fusion process.

Top Strategies Followed by Global Bone Growth Stimulator Market Players

• Leading companies in the global bone growth stimulator market focus extensively on research and development to innovate high-performance products
  • For example, in January 2024, Medtronic announced a US$ 150 million investment aimed at enhancing its regenerative medicine portfolio, which includes advanced bone growth stimulators designed to improve healing times. This allows them to develop novel technologies like implantable and smartphone-controlled bone growth stimulators with improved effectiveness. Sustained investment in R&D helps them strengthen their product portfolios and market dominance.
• Mid-sized companies in the market strive to deliver quality and cost-effective bone growth stimulation solutions targeting price-sensitive consumers. They leverage low-cost production methods and select niche applications to offer budget-friendly products without compromising on quality.
  • For example, Ellipse Technologies manufactures affordable ultrasound-based stimulators for home use. Such approaches aid their goal of capturing more market share.
• Small players in the industry often focus on specialized markets by developing innovative products with unique features. A company like Mecta Labs produces 3D-printed, custom-shaped stimulators tailored to individual bone defects. Its expertise in 3D printing helps meet niche needs not addressed by other stimulators. Such specialization strategies assist small companies in gaining a foothold in the competitive market.

Emerging Startups - Bone Growth Stimulator Industry Ecosystem

• Innovative Technologies: Startups like StimRouter are developing advanced neuromodulation-based bone healing technologies using miniaturized and customized stimulators. If proven effective, such innovation has potential to transform the treatment of complex bone fractures. Other startups apply opportunities presented by AI, sensors, and simulation to optimize stimulation protocols. The influence of these emerging technologies on non-union fracture repair could be significant in the coming years.
• Sustainable Solutions: A number of startups are focused on more environmentally-friendly solutions. Skeletech produces biodegradable, 3D-printed PLA scaffolds that eliminate metal implant waste. Corentec employs ultrasound-stimulated bone grafts derived from patients' own fat cells, minimizing donor site morbidity. These sustainable methods have the potential to address growing environmental concerns effectively.